137 related articles for article (PubMed ID: 36471108)
1. Role of biological effective dose for prediction of endocrine remission in acromegaly patients treated with stereotactic radiosurgery.
Dumot C; Schlesinger D; Mantziaris G; Dayawansa S; Xu Z; Sheehan JP
Pituitary; 2023 Feb; 26(1):124-131. PubMed ID: 36471108
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study.
Graffeo CS; Donegan D; Erickson D; Brown PD; Perry A; Link MJ; Young WF; Pollock BE
Neurosurgery; 2020 Sep; 87(3):538-546. PubMed ID: 32267504
[TBL] [Abstract][Full Text] [Related]
3. Biological Effective Dose as a Predictor of Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis and Cohort Study of Patients Treated Using Contemporary Techniques.
Graffeo CS; Perry A; Link MJ; Brown PD; Young WF; Pollock BE
Neurosurgery; 2021 Mar; 88(4):E330-E335. PubMed ID: 33469668
[TBL] [Abstract][Full Text] [Related]
4. Gamma Knife radiosurgery for acromegaly: Evaluating the role of the biological effective dose associated with endocrine remission in a series of 42 consecutive cases.
Balossier A; Tuleasca C; Cortet-Rudelli C; Soto-Ares G; Levivier M; Assaker R; Reyns N
Clin Endocrinol (Oxf); 2021 Mar; 94(3):424-433. PubMed ID: 32984972
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Radiosurgery for Acromegaly: An International Multicenter Retrospective Cohort Study.
Ding D; Mehta GU; Patibandla MR; Lee CC; Liscak R; Kano H; Pai FY; Kosak M; Sisterson ND; Martinez-Alvarez R; Martinez-Moreno N; Mathieu D; Grills IS; Blas K; Lee K; Cifarelli CP; Katsevman GA; Lee JYK; McShane B; Kondziolka D; Lunsford LD; Vance ML; Sheehan JP
Neurosurgery; 2019 Mar; 84(3):717-725. PubMed ID: 29757421
[TBL] [Abstract][Full Text] [Related]
6. Endocrine Remission After Pituitary Stereotactic Radiosurgery: Differences in Rates of Response for Matched Cohorts of Cushing Disease and Acromegaly Patients.
Trifiletti DM; Xu Z; Dutta SW; Quiñones-Hinojosa A; Peterson J; Vance ML; Sheehan JP
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):610-617. PubMed ID: 29678528
[TBL] [Abstract][Full Text] [Related]
7. Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function: an international multicenter study.
Pomeraniec IJ; Xu Z; Lee CC; Yang HC; Chytka T; Liscak R; Martinez-Alvarez R; Martinez-Moreno N; Attuati L; Picozzi P; Kondziolka D; Mureb M; Bernstein K; Mathieu D; Maillet M; Ogino A; Long H; Kano H; Lunsford LD; Zacharia BE; Mau C; Tuanquin LC; Cifarelli C; Arsanious D; Hack J; Warnick RE; Strickland BA; Zada G; Chang EL; Speckter H; Patel S; Ding D; Sheehan D; Sheehan K; Kvint S; Buch LY; Haber AR; Shteinhart J; Vance ML; Sheehan JP
J Neurosurg; 2022 Mar; 136(3):813-821. PubMed ID: 34560630
[TBL] [Abstract][Full Text] [Related]
8. Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis Based on Patients Treated Using Contemporary Techniques.
Graffeo CS; Link MJ; Brown PD; Young WF; Pollock BE
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):618-623. PubMed ID: 29678524
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgery for acromegaly.
Lee CC; Vance ML; Xu Z; Yen CP; Schlesinger D; Dodson B; Sheehan J
J Clin Endocrinol Metab; 2014 Apr; 99(4):1273-81. PubMed ID: 24471574
[TBL] [Abstract][Full Text] [Related]
10. Outcomes After Gamma Knife Stereotactic Radiosurgery in Pediatric Patients with Cushing Disease or Acromegaly: A Multi-Institutional Study.
Shrivastava A; Mohammed N; Xu Z; Liščák R; Kosak M; Krsek M; Karim KA; Lee CC; Martínez-Moreno N; Lee Vance M; Lunsford LD; Sheehan JP
World Neurosurg; 2019 May; 125():e1104-e1113. PubMed ID: 30790739
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiosurgery for secretory pituitary adenomas: systematic review and International Stereotactic Radiosurgery Society practice recommendations.
Mathieu D; Kotecha R; Sahgal A; De Salles A; Fariselli L; Pollock BE; Levivier M; Ma L; Paddick I; Regis J; Yomo S; Suh JH; Rubens M; Sheehan JP
J Neurosurg; 2022 Mar; 136(3):801-812. PubMed ID: 34479203
[TBL] [Abstract][Full Text] [Related]
12. Whole Sella vs Targeted Stereotactic Radiosurgery for Acromegaly: A Multicenter Matched Cohort Study.
Taylor DG; Janssen A; Ding D; Xu Z; Mehta GU; Liscak R; Kano H; Kosak M; Martinez-Moreno N; Hobbs L; Chen CJ; Grills IS; Mathieu D; Lunsford LD; Vance ML; Sheehan JP
Neurosurgery; 2020 May; 86(5):656-664. PubMed ID: 31384920
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of repeat radiosurgery for acromegaly: an International Multi-Institutional Study.
Alonso CE; Bunevicius A; Trifiletti DM; Larner J; Lee CC; Pai FY; Liscak R; Kosak M; Kano H; Sisterson ND; Mathieu D; Lunsford LD; Sheehan JP
J Neurooncol; 2019 Nov; 145(2):301-307. PubMed ID: 31541405
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report.
Grant RA; Whicker M; Lleva R; Knisely JP; Inzucchi SE; Chiang VL
World Neurosurg; 2014; 82(1-2):195-201. PubMed ID: 23385448
[TBL] [Abstract][Full Text] [Related]
15. Fractionated radiotherapy and radiosurgery in acromegaly: analysis of 352 patients from the German Acromegaly Registry.
Knappe UJ; Petroff D; Quinkler M; Schmid SM; Schöfl C; Schopohl J; Stieg MR; Tönjes A;
Eur J Endocrinol; 2020 Mar; 182(3):275-284. PubMed ID: 31917680
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype.
Lee CC; Vance ML; Lopes MB; Xu Z; Chen CJ; Sheehan J
Pituitary; 2015 Jun; 18(3):326-34. PubMed ID: 24925503
[TBL] [Abstract][Full Text] [Related]
17. Upfront Gamma Knife radiosurgery for Cushing's disease and acromegaly: a multicenter, international study.
Gupta A; Xu Z; Kano H; Sisterson N; Su YH; Krsek M; Nabeel AM; El-Shehaby A; Karim KA; Martínez-Moreno N; Mathieu D; McShane BJ; Martínez-Álvarez R; Reda WA; Liscak R; Lee CC; Lunsford LD; Sheehan JP
J Neurosurg; 2018 Aug; 131(2):532-538. PubMed ID: 30117768
[TBL] [Abstract][Full Text] [Related]
18. Hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
Xu Z; Lee Vance M; Schlesinger D; Sheehan JP
Neurosurgery; 2013 Apr; 72(4):630-7; 636-7. PubMed ID: 23277375
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution.
Kong DS; Lee JI; Lim DH; Kim KW; Shin HJ; Nam DH; Park K; Kim JH
Cancer; 2007 Aug; 110(4):854-60. PubMed ID: 17599761
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting early versus late remission in acromegaly following stereotactic radiosurgery.
Patibandla MR; Xu Z; Sheehan JP
J Neurooncol; 2018 May; 138(1):209-216. PubMed ID: 29417401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
